carnosine has been researched along with Peripheral Nerve Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egashira, N; Kaname, T; Kawashiri, T; Shiraishi, H; Tsutsumi, K | 1 |
| El Abhar, H; Saad, AS; Saleh, S; Schaalan, M; Yehia, R | 1 |
1 trial(s) available for carnosine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
L-Carnosine protects against Oxaliplatin-induced peripheral neuropathy in colorectal cancer patients: A perspective on targeting Nrf-2 and NF-κB pathways.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Apoptosis; Carnosine; Caspase 3; Colorectal Neoplasms; Egypt; Female; Fluorouracil; Humans; Leucovorin; Male; Malondialdehyde; Middle Aged; Neuroprotective Agents; NF-E2-Related Factor 2; NF-kappa B; Organoplatinum Compounds; Oxaliplatin; Peripheral Nerves; Peripheral Nervous System Diseases; Pilot Projects; Prospective Studies; Signal Transduction; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Young Adult | 2019 |
1 other study(ies) available for carnosine and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Polaprezinc reduces paclitaxel-induced peripheral neuropathy in rats without affecting anti-tumor activity.
Topics: Analgesics; Animals; Antineoplastic Agents, Phytogenic; Carnosine; Cell Line, Tumor; Cell Survival; Hyperalgesia; Male; Mice; Mice, Inbred C57BL; Neoplasms; Organometallic Compounds; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley; Tumor Burden; Zinc Compounds | 2016 |